Free Cash Flow Investing: Why VFLO Holds Merck Amid Healthcare Headwinds
Published on May 12, 2026
In the current market, broad healthcare exposure means navigating relentless regulatory pressure and drug-pricing reform, a combination that can erode returns quickly. To find true value in this challenging macro environment, investors are increasingly turning to cash as the ultimate truth-teller, specifically, free cash flow (FCF).